Stock Alert: Tata Power Company, Mishra Dhatu Nigam, DCX Systems, Bajaj Finance

Kaynes Technology India was under the futures and options (F&O) ban period on 12 November 2026.

Results Today:

Alkem Laboratories, Amber Enterprises India, Hindustan Aeronautics, Manappuram Finance, Oil India, Ola Electric Mobility, Bharat Dynamics, Vodafone Idea, Bonfiglioli Transmissions, Dilip Buildcon, EIH, Elevate Campuses, EMS, Indian Railway Catering and Tourism Corporation, Rays of Belief, NMDC, Page Industries, Hitachi Energy India, Rashtriya Chemicals and Fertilizers, Rail Vikas Nigam, Travel Food Services, and Turtlemint Fintech Solutions will release their quarterly earnings on November 12.

Stocks to Watch:

Mishra Dhatu Nigam reported a 114.8% increase in consolidated net profit to Rs 27.8 crore in Q2 FY27 from Rs 13 crore in Q2 FY26. Revenue from operations increased 41.1% to Rs 295.9 crore from Rs 209.7 crore.

Tata Power Company reported a 48.58% increase in consolidated net profit to Rs 1,366.1 crore in Q2 FY27 from Rs 919.4 crore in Q2 FY26. Revenue from operations increased 26.3% to Rs 19,635.9 crore from Rs 15,544.9 crore. The net profit includes an exceptional gain of Rs 119.2 crore during the quarter. The company's board approved an investment of Rs 11,871 crore for setting up an 1,800 MW pumped storage project in Maharashtra. The board also appointed Sanjay Banga as an additional director and CEO designate, effective 11 November 2026. He will assume the position of managing director and CEO for a five-year term from 1 May 2027.

Triveni Turbine reported a 41.6% decline in consolidated net profit to Rs 53.3 crore in Q2 FY27 from Rs 91.2 crore in Q2 FY26. Revenue from operations declined 3% to Rs 491 crore from Rs 506.2 crore.

DCX Systems reported a consolidated net loss of Rs 0.25 crore in Q2 FY27 as against a net loss of Rs 9.04 crore in Q2 FY26. Revenue from operations declined 27.3% to Rs 140.2 crore from Rs 192.9 crore.

Bajaj Finance launched its qualified institutions placement (QIP) on 11 November 2026, with the floor price fixed at Rs 992.25 per equity share. The company may offer a discount of up to 5% on the floor price.

Aurobindo Pharma announced that the US Food and Drug Administration (US FDA) has classified the inspection outcome for the Seymour facility of Lannett Company LLC, a wholly owned step-down subsidiary, as Official Action Indicated (OAI). The US FDA conducted an inspection at the facility from 17 to 21 August 2026 and issued four observations. The company responded to the observations within the stipulated timeframe.

Powered by Capital Market - Live News